HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Viracept (Nelfinavir)

The Basics | News | Research

Show Archived (Historical) Articles

Brand Name:	Viracept
Generic Name:	Nelfinavir, NFV
Adult Single Dose:	Two 625-mg tablets (twice a day) OR three 250-mg tablets (three times a day) OR five 250-mg tablets (twice a day)
Food & Liquid Restrictions:	Take with a meal
Drug Class:	PI

The Basics

An Overview of Viracept (Nelfinavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Viracept (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Nelfinavir (Viracept) (October 10, 2008)
To read PDF, click here
From AIDS InfoNet
Patient Information About Viracept (Nelfinavir) (PDF) (September 2008)
From Pfizer, Inc.
Viracept (Nelfinavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Nelfinavir (Viracept) (August 15, 2006)
From AIDS Treatment Data Network

News

Viracept (Nelfinavir Mesylate) 250 mg, 625 mg Tablets, and Powder for Oral Suspension: Important Information for Prescribers (PDF) (May 6, 2008)
From Pfizer, Inc.
Heavy Restrictions on Nelfinavir Use Recommended for Pediatric Patients, Pregnant Women in United States (September 10, 2007)
From U.S. Food and Drug Administration
European Union Suspends Roche HIV Drug Due to Toxic Contamination (August 7, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Roche Admits Long-Standing, Low-Level Contamination of Nelfinavir (July 26, 2007)
New information reveals contamination dating back to the drug's release in 1998; United States, Canada and Japan are the only unaffected countries.
From aidsmap.com
Viracept Recall Creates Panic in Zambia (June 19, 2007)
From United Nations Integrated Regional Information Networks
European Medicines Agency Recalls Roche Antiretroviral Viracept Because of Contamination (June 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.